Author's response to Letter to the Editor by Kauffman et al. published in JNI 212/1–2, June 2009

References 

1. Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L, et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology. 1999;53:1361–1363
   • MEDLINE
   • CrossRef
2. Kauffman MA, Moron DG, Sandoval G, Sica RE, Garcea O, Villa AM. Is tumor necrosis factor −376a promoter polymorphism associated with susceptibility to multiple sclerosis?. Med. B. Aires. 2007;67:436–438
3. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007;17:210–218
   • MEDLINE
   • CrossRef
4. Losonczi E, Bencsik K, Nagy ZF, Honti V, Szalczer E, Rajda C, et al. Tumour necrosis factor alpha gene (TNF-alpha) −376 polymorphism in Hungarian patients with primary progressive multiple sclerosis. J. Neuroimmunol. 2009;208:115–118
   • Abstract
   • Full Text
   • Full-Text PDF (160 KB)
   • CrossRef
5. Martínez A, Rubio A, Urcelay E, Fernandez-Arquero M, de las Heras V, Arroyo R, et al. TNF-376A marks susceptibility to MS in the Spanish population. A replication study. Neurology. 2004;62:809–810
   • CrossRef
6. Wirz S, Morale M, Marchetti B, Barr A, Sotgiu S, Rosati G, et al. High frequency of TNF alleles −238A and −376A in individuals from northern Sardinia. Cytokine Growth Factor Rev. 2004;26:149–154